This review article written by Danielle Gentile, PhD, et al, reviews the management of cancer-related fatigue in integrative oncology. ABSTRACT Cancer-related fatigue (CRF) is one of the most common symptoms across the cancer continuum and is often underreported and undertreated. Defined as a distressing, persistent, subjective sense of tiredness or […]
Practice
Olaparib in gBRCA+ Breast Cancer; ‘Clearly Practice Changing’
Adjuvant olaparib (Lynparza) significantly improves overall survival (OS), compared with placebo, for patients with high-risk, early-stage, HER2-negative, germline BRCA-mutated breast cancer, according to the latest results from the pivotal phase 3 OlympiA trial. Olaparib was recently approved for this indication, as reported by Medscape Medical News; the approval was based […]